Skip to content
OpenCapital
Get started

Aquestive Therapeutics, Inc. AQST Selling Expense

Selling Expense at other companies

RVL
Revolve GroupRVLV
$57.7M+15.5%
Balchem logo
BalchemBCPC
$21.1M+24.6%
United Airlines Holdings logo
United Airlines HoldingsUAL
$522M+5.2%
Abercrombie & Fitch logo
Abercrombie & FitchANF
$431.2M+7.8%
Teladoc Health logo
Teladoc HealthTDOC
$51.28M+5.3%
Matthews International logo
Matthews InternationalMATW
$26.13M-29.3%

Segments

By product

See full
Other$6.48M+128%
Personnel costs$1.61M+169%

By segment

See full
Reportable Segment$1.92M-35.0%

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%—
Debt / equity-1.9×—
Current ratio4.1×-0.8×